In the News
No link between vitamin D, omega-3 fatty acid supplements and improved kidney function
An ancillary analysis of the Vitamin D and Omega-3 Trial (VITAL) included 1,312 adult patients with type 2 diabetes who agreed to additional testing of kidney function and urinary albumin excretion at baseline and two and five years after randomization.
Frequency of outpatient visits for diabetes not associated with glycemic control
The frequency of diabetes visits varied across health systems, but within most of the studied organizations, patients with high HbA1c levels were not seen any more often than those with lower levels.
Diabetes apps require additional validation, education on their use, consensus report finds
Clinicians should be aware of the strengths and weaknesses of diabetes apps and be able to advise patients on their use, according to the European Association for the Study of Diabetes and the American Diabetes Association.
MKSAP quiz: Screening after diagnosis
This month's quiz asks readers to choose screening tests for a 55-year-old man who was diagnosed with type 2 diabetes mellitus based on two HbA1c measurements of 7.8%.
Spotlight on diabetes, drugs, and dementia
Low-dose aspirin was associated with reduced risk of dementia in women but not men with diabetes, and long-term use of metformin was associated with lower risk of Alzheimer's disease among patients with diabetes.
Annals On Call: Technology to improve diabetes management
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. This episode covers “Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.”
Recovery from metabolic syndrome reduces cardiovascular risk, Korean study finds
The large retrospective study found that hypertension was the metabolic syndrome component with the largest associated increase in risk for a major cardiovascular event.
Dilemmas in diabetes
The cover story of the December ACP Hospitalist addresses dilemmas in inpatient diabetes care, including new drugs and insulin pumps.
Metformin may contain nitrosamine impurity
The FDA is investigating whether metformin in the U.S. market contains N-nitrosodimethylamine. Low levels of the impurity have been found in the drug in other countries; however, there are no U.S. recalls at this time.